Cargando…
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) is an attractive therapeutic strategy for targeting cancer metabolism. So far, many potent NAMPT inhibitors have been developed and shown to bind to two unique tunnel-shaped cavities existing adjacent to each active site of a NAMPT homodim...
Autores principales: | Tanuma, Sei-ichi, Katsuragi, Kiyotaka, Oyama, Takahiro, Yoshimori, Atsushi, Shibasaki, Yuri, Asawa, Yasunobu, Yamazaki, Hiroaki, Makino, Kosho, Okazawa, Miwa, Ogino, Yoko, Sakamoto, Yoshimi, Nomura, Miyuki, Sato, Akira, Abe, Hideaki, Nakamura, Hiroyuki, Takahashi, Hideyo, Tanuma, Nobuhiro, Uchiumi, Fumiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464552/ https://www.ncbi.nlm.nih.gov/pubmed/32785052 http://dx.doi.org/10.3390/molecules25163633 |
Ejemplares similares
-
Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment
por: Ogino, Yoko, et al.
Publicado: (2018) -
The possible functions of duplicated ets (GGAA) motifs located near transcription start sites of various human genes
por: Uchiumi, Fumiaki, et al.
Publicado: (2011) -
The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-β of the OAS1 anti-viral gene
por: Larsen, Steven, et al.
Publicado: (2015) -
Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves’ opthalmopathy
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2016) -
PARP1 gene expression is downregulated by knockdown of PARG gene
por: UCHIUMI, FUMIAKI, et al.
Publicado: (2013)